Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
15 févr. 2024 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that it will host a conference call starting at 3...
Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
14 févr. 2024 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that it has engaged IR Labs, Inc. (“irlabs”) to...
Generic Oncology Drugs Global Research Report 2023: Market to Reach $33.18 Billion by 2027, Propelled by Rising Cancer Prevalence and Novel Formulations - Long-term Forecasts to 2032
08 févr. 2024 09h38 HE
|
Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Generic Oncology Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global market for generic oncology...
Europe Constrained Peptide Drugs Market Analysis and Forecast, 2024-2040: Market to Grow by Over $6.5 Billion at a CAGR of 41.55%, Driven by Innovative Pipeline Drugs that Target More than Receptors
06 févr. 2024 08h58 HE
|
Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Europe Constrained Peptide Drugs Market: Analysis and Forecast, 2024-2040" report has been added to ResearchAndMarkets.com's offering.The market size...
MPH966 (Alvelestat) Drug Insight with Market Projections to 2032: A Novel Therapy Under Development for Bronchiolitis Obliterans Syndrome (BOS)
30 janv. 2024 10h51 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MPH966 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth...
TTP399 Drug Insights and Forecasts Across the 7MM, 2023-2032
29 janv. 2024 12h31 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "TTP399 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The research outlined in this...
Emerging ONC201 Drug Set to Transform Glioblastoma Multiforme Treatment Landscape: Drug Insights and Market Forecasts to 2032
29 janv. 2024 12h18 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "ONC201 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
Global Biosimulation Market to Surge, Predicted CAGR of 16.98% from 2024 to 2034, Driven by Pharmaceutical R&D and Technological Advancements
29 janv. 2024 10h53 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market" report has been added to ResearchAndMarkets.com's offering. The advent of cutting-edge biosimulation technologies is...
Ursolic Acid Market Growth Fueled by Rising Demand in Cosmetic and Nutraceutical Industries – New Global Report Analyzes Key Trends
26 janv. 2024 10h54 HE
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Ursolic Acid Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global interest in plant-derived compounds has...
Emerging Drug Insight and Market Forecasts for YG1699 in Type 1 Diabetes Mellitus, 2019-2023 and 2023-2032
24 janv. 2024 09h12 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "YG1699 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Understanding the future market...